NewAmsterdam Pharma Co N.V.·4

Jun 3, 5:02 PM ET

Marino Michael F III 4

4 · NewAmsterdam Pharma Co N.V. · Filed Jun 3, 2025

Insider Transaction Report

Form 4
Period: 2025-06-01
Transactions
  • Award

    Ordinary Shares

    2025-06-01+55,00055,000 total
  • Award

    Option (right to buy)

    2025-06-01+315,000315,000 total
    Exercise: $18.11Exp: 2035-06-01Ordinary Shares (315,000 underlying)
Footnotes (3)
  • [F1]Represents restricted stock units ("RSUs"), each representing a contingent right to receive one ordinary share. 1/3 of the RSUs will vest on each of the first, second and third anniversaries of the vesting start date, subject to the Reporting Person's continued service through each such date.
  • [F2]Each RSU was granted on June 1, 2025 for no consideration.
  • [F3]25% of the shares underlying the option will vest on June 1, 2026, the one-year anniversary of the vesting start date, with the remaining shares vesting in equal monthly installments thereafter for three years, subject to the Reporting Person's continued service through each such date.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4